Literature DB >> 22535953

Human high temperature requirement serine protease A1 (HTRA1) degrades tau protein aggregates.

Annette Tennstaedt1, Simon Pöpsel, Linda Truebestein, Patrick Hauske, Anke Brockmann, Nina Schmidt, Inga Irle, Barbara Sacca, Christof M Niemeyer, Roland Brandt, Hanna Ksiezak-Reding, Anca Laura Tirniceriu, Rupert Egensperger, Alfonso Baldi, Leif Dehmelt, Markus Kaiser, Robert Huber, Tim Clausen, Michael Ehrmann.   

Abstract

Protective proteases are key elements of protein quality control pathways that are up-regulated, for example, under various protein folding stresses. These proteases are employed to prevent the accumulation and aggregation of misfolded proteins that can impose severe damage to cells. The high temperature requirement A (HtrA) family of serine proteases has evolved to perform important aspects of ATP-independent protein quality control. So far, however, no HtrA protease is known that degrades protein aggregates. We show here that human HTRA1 degrades aggregated and fibrillar tau, a protein that is critically involved in various neurological disorders. Neuronal cells and patient brains accumulate less tau, neurofibrillary tangles, and neuritic plaques, respectively, when HTRA1 is expressed at elevated levels. Furthermore, HTRA1 mRNA and HTRA1 activity are up-regulated in response to elevated tau concentrations. These data suggest that HTRA1 is performing regulated proteolysis during protein quality control, the implications of which are discussed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22535953      PMCID: PMC3375517          DOI: 10.1074/jbc.M111.316232

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  61 in total

1.  Tau paired helical filaments from Alzheimer's disease brain and assembled in vitro are based on beta-structure in the core domain.

Authors:  Stefan Barghorn; Peter Davies; Eckhard Mandelkow
Journal:  Biochemistry       Date:  2004-02-17       Impact factor: 3.162

2.  Crystal structure of the DegS stress sensor: How a PDZ domain recognizes misfolded protein and activates a protease.

Authors:  Corinna Wilken; Karina Kitzing; Robert Kurzbauer; Michael Ehrmann; Tim Clausen
Journal:  Cell       Date:  2004-05-14       Impact factor: 41.582

3.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease.

Authors:  S S Mirra; A Heyman; D McKeel; S M Sumi; B J Crain; L M Brownlee; F S Vogel; J P Hughes; G van Belle; L Berg
Journal:  Neurology       Date:  1991-04       Impact factor: 9.910

4.  Tau released from paired helical filaments with formic acid or guanidine is susceptible to calpain-mediated proteolysis.

Authors:  L S Yang; W Gordon-Krajcer; H Ksiezak-Reding
Journal:  J Neurochem       Date:  1997-10       Impact factor: 5.372

5.  Straight and paired helical filaments in Alzheimer disease have a common structural unit.

Authors:  R A Crowther
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

6.  Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line.

Authors:  J P Morgenstern; H Land
Journal:  Nucleic Acids Res       Date:  1990-06-25       Impact factor: 16.971

7.  Composition and proteolytic processing of corneal deposits associated with mutations in the TGFBI gene.

Authors:  Henrik Karring; Kasper Runager; Ida B Thøgersen; Gordon K Klintworth; Peter Højrup; Jan J Enghild
Journal:  Exp Eye Res       Date:  2011-12-03       Impact factor: 3.467

8.  Substrate specificities of caspase family proteases.

Authors:  R V Talanian; C Quinlan; S Trautz; M C Hackett; J A Mankovich; D Banach; T Ghayur; K D Brady; W W Wong
Journal:  J Biol Chem       Date:  1997-04-11       Impact factor: 5.157

9.  Differential sensitivity to proteolysis by brain calpain of adult human tau, fetal human tau and PHF-tau.

Authors:  M Mercken; F Grynspan; R A Nixon
Journal:  FEBS Lett       Date:  1995-07-10       Impact factor: 4.124

10.  Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology.

Authors:  Robert A Rissman; Wayne W Poon; Mathew Blurton-Jones; Salvatore Oddo; Reidun Torp; Michael P Vitek; Frank M LaFerla; Troy T Rohn; Carl W Cotman
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

View more
  40 in total

Review 1.  Roles of tau protein in health and disease.

Authors:  Tong Guo; Wendy Noble; Diane P Hanger
Journal:  Acta Neuropathol       Date:  2017-04-06       Impact factor: 17.088

Review 2.  Designer protein disaggregases to counter neurodegenerative disease.

Authors:  James Shorter
Journal:  Curr Opin Genet Dev       Date:  2017-02-14       Impact factor: 5.578

3.  Changes in the detergent-insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progression.

Authors:  Chadwick M Hales; Eric B Dammer; Qiudong Deng; Duc M Duong; Marla Gearing; Juan C Troncoso; Madhav Thambisetty; James J Lah; Joshua M Shulman; Allan I Levey; Nicholas T Seyfried
Journal:  Proteomics       Date:  2016-12       Impact factor: 3.984

4.  Age-related macular degeneration-associated silent polymorphisms in HtrA1 impair its ability to antagonize insulin-like growth factor 1.

Authors:  Sarah Melissa P Jacobo; Margaret M Deangelis; Ivana K Kim; Andrius Kazlauskas
Journal:  Mol Cell Biol       Date:  2013-03-11       Impact factor: 4.272

5.  HtrA1 Proteolysis of ApoE In Vitro Is Allele Selective.

Authors:  Qian Chu; Jolene K Diedrich; Joan M Vaughan; Cynthia J Donaldson; Michael F Nunn; Kuo-Fen Lee; Alan Saghatelian
Journal:  J Am Chem Soc       Date:  2016-07-19       Impact factor: 15.419

6.  The serine protease HtrA1 contributes to the formation of an extracellular 25-kDa apolipoprotein E fragment that stimulates neuritogenesis.

Authors:  Sonia Sanz Muñoz; Hongyun Li; Kalani Ruberu; Qian Chu; Alan Saghatelian; Lezanne Ooi; Brett Garner
Journal:  J Biol Chem       Date:  2018-02-02       Impact factor: 5.157

7.  Determinants of amyloid fibril degradation by the PDZ protease HTRA1.

Authors:  Simon Poepsel; Andreas Sprengel; Barbara Sacca; Farnusch Kaschani; Markus Kaiser; Christos Gatsogiannis; Stefan Raunser; Tim Clausen; Michael Ehrmann
Journal:  Nat Chem Biol       Date:  2015-10-05       Impact factor: 15.040

8.  Cerebral small vessel disease-related protease HtrA1 processes latent TGF-β binding protein 1 and facilitates TGF-β signaling.

Authors:  Nathalie Beaufort; Eva Scharrer; Elisabeth Kremmer; Vanda Lux; Michael Ehrmann; Robert Huber; Henry Houlden; David Werring; Christof Haffner; Martin Dichgans
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-04       Impact factor: 11.205

9.  Near-atomic model of microtubule-tau interactions.

Authors:  Elizabeth H Kellogg; Nisreen M A Hejab; Simon Poepsel; Kenneth H Downing; Frank DiMaio; Eva Nogales
Journal:  Science       Date:  2018-05-10       Impact factor: 47.728

10.  Serine protease HtrA1 accumulates in corneal transforming growth factor beta induced protein (TGFBIp) amyloid deposits.

Authors:  Henrik Karring; Ebbe Toftgaard Poulsen; Kasper Runager; Ida B Thøgersen; Gordon K Klintworth; Peter Højrup; Jan J Enghild
Journal:  Mol Vis       Date:  2013-04-12       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.